How Psychedelic Drugs Became a Hot Investment

Andrew Jacobs New York Times May 10, 2021

Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences.